Fulvestrant

Fulvestrant
Product Description

an anti-cancer drug, Bulk and injection (PFS): 250mg in 5ml

Hangzhou Jiuyuan Gene Engineering Co.,Lt

  • CN
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    129453-61-8

Hangzhou Jiuyuan Gene Engineering Co.,Lt

  • CN
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

More Products from Hangzhou Jiuyuan Gene Engineering Co.,Lt (16)

  • rhBMP-2

    Product rhBMP-2

    a new bone repairing materialbrhrbrrecombinant human Bone Morphogenetic Protein-2, bone reparing, BMP-2, BMP
  • semaglutide

    Product semaglutide

    diabetes (recombinant route),  API
  • Semaglutide

    Product Semaglutide

    Diabetes and Obesity
  • Filgrastim

    Product Filgrastim

    Filgrastim, Neupogen, G-CSF, Indicated to neutropenia, Formulated bulk liquid, l  Injection (ampoule/PFS/vial) 75µg/unit, 150µg/unit, 300µg/unit, 450µg/unit

  • Fosaprepitant dimeglumine

    Product Fosaprepitant dimeglumine

    cancerbrhrbrEmend, CAS number: 265121-04-8
  • Dulaglutide

    Product Dulaglutide

    diabetes (recombinant route), API
  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapy, Active pharmaceutical ingredient (API) , Injection (ampoule): 0.25mg/5ml


  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapy, Active pharmaceutical ingredient (API),Injection (ampoule): 0.25mg/5ml

  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapybrhrbrPalonosetron, Aloxi
  • Pegfilgrastim

    Product Pegfilgrastim

    long lasting filgrastim, pegylated filgrastim, neulasta
  • PegFilgrastim

    Product PegFilgrastim

    a long lasting rhG-CSF, Bulk and injection (PFS): 6mg in 0.6ml
  • Ranibizumab

    Product Ranibizumab

    Wet Macular Degeneration, API